The associate attending physician at Memorial Sloan Kettering Cancer Center discussed further research that remains to be conducted with the allogeneic cell therapy.
Sham Mailankody, MBBS
Advertisement
Articles by Sham Mailankody, MBBS
The associate attending physician at Memorial Sloan Kettering Cancer Center discussed updated data presented at the ASH 2022 meeting.
Sham Mailankody, MBBS, discusses research regarding the BCMA CAR T-cell therapy bb2121 in patients with relapsed/refractory multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Mailankody on BCMA CAR T-Cell Therapy in Relapsed/Refractory Multiple MyelomaPublished: December 5th 2019 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program
2
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again
5
